THE IMPACT OF DIABETES AND AGE ON PERFORMANCE OF NON-INVASIVE SERUM-BASED TESTS FOR PREDICTION OF ADVANCED FIBROSIS IN BIOPSY-PROVEN NAFLD

被引:0
|
作者
Kosick, Heather [1 ,2 ]
Adeyi, Oyedele A. [3 ]
Sebastiani, Giada [4 ,5 ]
Patel, Keyur [6 ]
Shengir, Mohamed [4 ,7 ]
机构
[1] Univ Toronto, Gastroenterol, Toronto, ON, Canada
[2] Univ Hlth Network, Hepatol, Toronto, ON, Canada
[3] Univ Minnesota Med Sch, Dept Lab Med & Pathol, Minneapolis, MN USA
[4] Mcgill Univ Hlth Ctr, Hepatol, Montreal, PQ, Canada
[5] Mcgill Univ Hlth Ctr, Div Gastroenterol & Hepatol, Montreal, PQ, Canada
[6] Univ Hlth Network, Div Gastroenterol, Toronto, ON, Canada
[7] McGill Univ, Div Expt Med, Dept Med, Montreal, PQ, Canada
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1653
引用
收藏
页码:990A / 991A
页数:2
相关论文
共 50 条
  • [21] CAN ADVANCED FIBROSIS RELIABLY EXCLUDED BY SIMPLE NON-INVASIVE FIBROSIS SCORING SYSTEMS?: PERFORMANCE OF FIB-4 AND NFS IN A BIOPSY-PROVEN NON-ALCOHOLIC FATTY LIVER DISEASE SAMPLE
    Kaya, Eda
    Bakir, Alev
    Yilmaz, Yusuf
    HEPATOLOGY, 2019, 70 : 1053A - 1054A
  • [22] Serum-based Metabolomics-Advanced StEatohepatitis Fibrosis Score (MASEF) fot the non-invasive identification of patients with non-alcoholic steatohepatitis with significant fibrosis
    Noureddin, Mazen
    Mayo, Rebeca
    Martinez-Arranz, Ibon
    Minchole, Itziar
    Maria Banales, Jesus
    Miguel Rodrigues, Pedro
    Crespo, Javier
    Valenti, Luca
    Vitek, Libor
    Guindi, Maha
    Romero Gomez, Manuel
    Alonso, Cristina
    Iruzubieta, Paula
    Bril, Fernando
    Pablo, Ortiz
    Bruha, Radan
    Arrese, Marco
    Dufour, Jean-Francois
    Cusi, Kenneth
    Anstee, Quentin
    Mato, Jose M.
    Sanyal, Arun
    JOURNAL OF HEPATOLOGY, 2020, 73 : S136 - S136
  • [23] A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD
    Wang, Jian
    Huang, Rui
    Liu, Jiacheng
    Lai, Ruimin
    Liu, Yilin
    Zhu, Chuanwu
    Qiu, Yuanwang
    He, Zebao
    Yin, Shengxia
    Chen, Yuxin
    Yan, Xiaomin
    Ding, Weimao
    Zheng, Qi
    Li, Jie
    Wu, Chao
    JOURNAL OF VIRAL HEPATITIS, 2023, 30 (04) : 287 - 296
  • [24] ACCURACY OF FIB-4 FOR IDENTIFYING ADVANCED FIBROSIS AMONG PATIENTS WITH BIOPSY-PROVEN STEATOSIS AND STEATOHEPATITIS: IMPACT OF OBESITY AND DIABETES
    Kim, Rebecca
    Deng, Jasmine
    Reaso, Jewel
    Grenert, James P.
    Khalili, Mandana
    HEPATOLOGY, 2021, 74 : 929A - 929A
  • [25] Combination of Non-Invasive Fibrosis Tests: a Solution for the Prediction of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease?
    Lupsor-Platon, Monica
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2019, 28 (03) : 257 - 259
  • [26] PREDICTION OF ADVANCED FIBROSIS USING METABOLIC AND GENETIC FACTORS IN PATIENTS WITH BIOPSY-PROVEN NON-ALCOHOLIC FATTY LIVER DISEASE
    Kim, DongYun
    Lee, Jae Seung
    Lee, Hye Won
    Kim, Beom Kyung
    Kim, Seung Up
    Kim, Do Young, Sr.
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Park, Jun Yong
    HEPATOLOGY, 2019, 70 : 1045A - 1045A
  • [27] Referral pathways for patients with NAFLD based on non-invasive fibrosis tests: Diagnostic accuracy and cost analysis
    Crossan, Catriona
    Majumdar, Avik
    Srivastava, Ankur
    Thorburn, Douglas
    Rosenberg, William
    Pinzani, Massimo
    Longworth, Louise
    Tsochatzis, Emmanuel A.
    LIVER INTERNATIONAL, 2019, 39 (11) : 2052 - 2060
  • [28] DEVELOPMENTAND VALIDATION OF A NON-INVASIVE MODEL FOR PREDICTING FIBROSIS RESOLUTION ONE YEAR AFTER LIFESTYLE INTERVENTION FOR BIOPSY-PROVEN NON-ALCOHOLIC STEATOHEPATITIS
    Vilar-Gomez, E.
    Friedman, S.
    Calzadilla-Bertot, L.
    Yasells-Garcia, A.
    Gallego-Duran, R.
    Ampuero, J.
    Diago, M.
    Romero-Gomez, M.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S480 - S480
  • [29] Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study
    Cui, J.
    Ang, B.
    Haufe, W.
    Hernandez, C.
    Verna, E. C.
    Sirlin, C. B.
    Loomba, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (12) : 1271 - 1280
  • [30] Steatohepatitis and Fibrosis Influence the Occurrence of Type 2 Diabetes Mellitus during the Follow-up in Non-Diabetic Biopsy-Proven NAFLD Patients
    Ampuero, Javier
    Aller-De La Fuente, Rocio
    Gallego-Duran, Rocio
    Banales, Jesus
    Crespo, Javier
    Garcia-Monzon, Carmelo
    Luis Calleja, Jose
    Gomez-Camarero, Judith
    Iacono, Oreste L. O.
    Escudero-Garcia, Desamparados
    Albillos, Agustin
    Javier Garcia-Samaniego, Francisco
    Jorquera, Francisco
    Fernandez-Rodriguez, Conrado M.
    Caballeria, Juan
    Frances, Ruben
    Diago, Moises
    Romero-Gomez, Manuel
    HEPATOLOGY, 2018, 68 : 950A - 951A